TL;DR: ApoB (apolipoprotein B) counts how many artery-damaging particles are actually in your blood, and it predicts heart attacks better than the LDL cholesterol number you’ve been judged by your whole life. Every particle that drives heart disease carries exactly one ApoB, so ApoB is a headcount. LDL cholesterol is a weight. You can have a “normal” LDL and a dangerous ApoB at the same time, and that gap is where a lot of first heart attacks live. The major cardiology guidelines already say ApoB is the better marker. Most annual physicals still don’t order it. Apex’s optimization target is ApoB under 80 mg/dL. If a doctor told you your cholesterol “looked fine” off a standard panel, you don’t know your cardiac risk yet. You know cholesterol weight, and not the number that counts.

What Is ApoB, and Why Does It Beat LDL Cholesterol?

ApoB is a headcount of the particles that cause heart disease. LDL cholesterol is an estimate of their weight. Those are not the same measurement, and when they disagree, the headcount wins.

Here’s the biology in plain English. Atherosclerosis, the stuff that clogs arteries, is not caused by cholesterol floating loose in your blood. It’s caused by particles, lipoproteins, physically crossing into your artery wall and getting stuck there. LDL is the famous one, but VLDL, IDL, remnants, and Lp(a) all do it too. And every one of those particles carries exactly one molecule of apolipoprotein B on its surface. One particle, one ApoB. Always.

So when you measure ApoB, you are counting the trucks on the highway. When you measure LDL cholesterol, you are estimating how much cargo is sitting inside them.

That sounds like a technicality until you remember it’s the trucks that crash into the wall, not the cargo. It’s the number of particles, not the amount of cholesterol each one happens to carry, that determines how many get lodged in the artery and start a plaque. Sniderman and colleagues laid this out in JAMA Cardiology in 2019: ApoB, the particle count, tracks cardiovascular risk more tightly than the cholesterol concentration does.

Two men can have identical LDL cholesterol and a completely different number of particles carrying it. The one with more particles, each of them smaller and cholesterol-poor, has more trucks on the road and a higher risk. His LDL cholesterol number will never tell him that. His ApoB will.

Why Isn’t ApoB on Your Standard Cholesterol Panel?

Not because it’s exotic or expensive. Because the standard lipid panel is old, cheap, everywhere, and medicine runs on inertia.

The panel you’ve had a hundred times reports total cholesterol, HDL, triglycerides, and LDL. Here’s the part almost nobody tells you: on most of those panels, your LDL cholesterol was never measured. It was calculated, using the Friedewald equation, a formula published in 1972 that estimates LDL from the other three numbers. It is over fifty years old and it is still the default.

That formula has a specific, well-known failure mode. It gets less accurate as your triglycerides go up. Which means the exact people whose risk is being driven by a bad metabolic picture, high triglycerides, low HDL, insulin resistance, are the people whose LDL number is the least trustworthy. The calculation understates them. They get told they’re fine.

ApoB skips the estimate. It’s a direct measurement of the actual particle count, standardized, widely available, and it costs almost nothing on top of a normal draw. The barrier was never the lab. It was that “we’ve always done it this way,” and a cholesterol number that everyone already knows how to talk about.

What Does “Normal Cholesterol, High ApoB” Actually Mean?

It means you are one of the people the standard panel is built to miss. Your cholesterol weight looks average while your particle count is high, and the particle count is the thing that ends up in your artery wall.

Doctors call this discordance. It happens when your particles are small and cholesterol-depleted, so it takes more of them to carry the same total cholesterol. The lab adds up the cholesterol, gets a normal-looking LDL, and moves on. Meanwhile you’re driving around with a lot more trucks than that number implies.

Who ends up discordant? Overwhelmingly, people with a metabolic problem: insulin resistance, prediabetes, type 2 diabetes, a wide waist, high triglycerides, low HDL. This is the same crowd whose Friedewald LDL is already unreliable. So the failure stacks. Bad estimate, wrong direction, on the exact person who most needed the real number.

This is not a rounding error at the edge of medicine. In a large registry of patients hospitalized for a coronary event, nearly half had an LDL cholesterol under 100 mg/dL on admission. “Normal” cholesterol did not protect them. It described them, right up until the ambulance.

What Should Your ApoB Actually Be?

Under 80 mg/dL is the Apex optimization target. The lab’s “normal” flag will let you run much higher than that, and that is the whole problem.

Look at where the guidelines already sit. The 2019 ESC/EAS dyslipidemia guidelines set ApoB goals by risk: under 65 mg/dL for very-high-risk patients, under 80 mg/dL for high-risk patients. The 2018 AHA/ACC cholesterol guideline lists an ApoB of 130 mg/dL or higher as a “risk-enhancing factor,” their flag that you’re carrying more risk than your basic numbers suggest.

Now put that against a typical lab report, where ApoB won’t even get a red flag until it’s up around that 130 mark. That upper limit corresponds to an LDL cholesterol of roughly 160, a number nobody optimizing for a long life would accept. It’s the same story as the testosterone reference range built from a population that was never healthy: the “normal” band describes the average person, and the average person is metabolically unwell. Grading yourself against them is grading on a curve where the class is failing.

Apex targets ApoB under 80 because the goal isn’t to dodge the lab’s red flag. It’s to keep the lifetime number of particles hitting your artery wall as low as we reasonably can, which is the entire logic of the Peter Attia Medicine 3.0 model: act on the driver early, over decades, instead of waiting for the event.

Isn’t LDL Cholesterol Good Enough?

No, and there’s a clean piece of evidence on exactly this question. When you know a person’s ApoB, their LDL cholesterol stops adding much of anything.

Marston and colleagues looked at this directly in JAMA Cardiology in 2022. Across a large dataset, ApoB was the marker that carried the cardiovascular risk. Once ApoB was accounted for, LDL cholesterol and triglycerides added essentially no further predictive power. Read that plainly: the particle count explained the risk, and the cholesterol weight was mostly along for the ride.

This lines up with the deepest evidence we have on cause, not just correlation. Genetic studies, the Mendelian randomization work summarized by Ference and colleagues in the European Heart Journal in 2017, show that the damage tracks with lifetime particle exposure. More atherogenic particles, hitting the wall, over more years, equals more disease. That is a causal story, not a statistical coincidence, and ApoB is how you count the particles.

So “LDL is good enough” is defensible only if you never look at the people it misses. The discordant ones. The metabolically unwell ones. The ones whose calculated LDL came back reassuring. Those are not rare edge cases. That’s a huge share of the men walking around at 45 thinking they’re covered.

Who Gets Fooled by a “Perfect” Lipid Panel?

The people who feel healthy and have every reason to believe they are. That’s what makes it dangerous.

The classic miss:

• The lean guy with a hidden metabolic problem. Normal weight on the outside, insulin resistant on the inside, high triglycerides, low HDL. His LDL looks fine. His ApoB doesn’t.
• Anyone with prediabetes or type 2 diabetes. Particle number runs high even when cholesterol weight looks controlled.
• The patient “at goal” on a statin. Statins lower LDL cholesterol reliably, but a meaningful fraction of people hit their LDL target while their ApoB is still elevated. On paper they’re treated. By particle count they’re not.
• High triglycerides, low HDL, wide waist. The metabolic-syndrome signature. If that’s you, assume your calculated LDL is understating you until ApoB proves otherwise.

The through-line: the healthier your cholesterol panel looks while your metabolic markers are quietly bad, the more you need ApoB. The panel isn’t lying on purpose. It’s just measuring the wrong thing, the same mistake as trusting total testosterone when the number that matters is free. Right tube of blood, wrong number pulled out of it.

What a Real Cardiac-Risk Workup Actually Measures

Everything the standard panel skips, because the standard panel was built to be cheap, not complete. The point is to count particles and find the metabolic engine driving them.

What belongs on it:

• ApoB (the particle count, the headline number, target under 80)
• A full lipid panel with directly measured LDL where possible, not just the Friedewald estimate
• Triglycerides and HDL (read together, the metabolic tell)
• Lp(a) at least once in your life (a genetic, inherited particle that standard panels ignore entirely)
• Fasting insulin and HbA1c (insulin resistance is the engine behind high particle counts, and it shows up here years before glucose does)
• hs-CRP (vascular inflammation, the other half of the plaque story)
• A blood pressure and waist measurement to put the numbers in a body

Notice how much of that is metabolic, not cholesterol. That’s the point. ApoB tells you how many particles are on the road. The rest tells you why, and why is where the fix lives. A number without a cause is a scare. A number with a cause is a plan.

This is the logic Apex builds its panels around: measure ApoB and the metabolic markers driving it, then have a provider walk you through what they mean and what to actually do about it. It’s the same standard behind a real hormone workup that measures ApoB alongside your hormones and metabolic markers. Order your panel or book a consult here.

What the Gap Looks Like on a Real Report

A 48-year-old. Runs a few times a week, not overweight, no chest pain, no family drama he knows about. He gets the standard panel at his physical. Total cholesterol 195. HDL 41. Triglycerides 185. Calculated LDL 117. His doctor says the cholesterol is “basically fine, maybe cut back on red meat,” and he leaves relieved.

He comes to us and we pull the number nobody ordered. ApoB 118. Not fine. That’s a particle count sitting in risk-enhancing territory, and it was hiding in plain sight behind an unremarkable LDL. We keep going: fasting insulin 19, HbA1c 5.8. There’s the engine. He’s insulin resistant, his particles are small and numerous, his triglycerides and HDL were quietly telling that story, and the calculated LDL politely rounded it all off into “fine.”

His panel was normal. His ApoB was not. Both statements are true at the same time, and that’s the trap. His cardiologist wasn’t wrong about the LDL. He was reading the one number that couldn’t see the problem, and calling the absence of a signal an all-clear.

The fix wasn’t a scare. It was a target (ApoB under 80), the metabolic reason it was high, and a plan aimed at the reason. That plan only exists because somebody counted the particles.

What to Do If Your Cholesterol Is “Fine”

Ask one question at your next visit: what’s my ApoB? If the answer is “we didn’t run it,” you don’t have your cardiac risk yet. You have a cholesterol weight and a blind spot.

You can’t act on a number nobody measured. A normal LDL on a calculated panel, especially if your triglycerides run high or your waist is creeping, is not the reassurance it sounds like. It’s the number most likely to be wrong in the direction that lets you relax.

Get ApoB measured. Get it read next to your fasting insulin, your HbA1c, your triglycerides, and your Lp(a), by someone who will tell you what the particle count means and where the metabolic problem driving it actually sits. Then you have something you can move.

Managing cardiovascular risk is individual. ApoB targets, and anything you might do to reach them, depend on your full picture and your other risk factors, and belong in a conversation with a licensed provider, not a blog. Results vary from person to person. What doesn’t vary is this: you can’t lower a number you never counted.

You’ve probably been carrying a cardiac-risk estimate built on the one measurement designed to miss the problem. You deserve the headcount.

Apex runs ApoB inside a full metabolic and cardiovascular panel, measured and read the way the guidelines actually describe it, with a provider who explains the particle count, the metabolic drivers behind it, and what your specific numbers call for. Order your panel or book a consult here.

Chris Russell, PA-C is a co-founder of Apex Wellness, a performance medicine clinic specializing in hormone optimization, metabolic health, and longevity medicine. He practices in Georgia with multi-state licensure. Apex Wellness is LegitScript Certified.

This article is for educational purposes only and is not medical advice. It does not establish a provider-patient relationship. Cardiovascular risk assessment and any treatment require an individual evaluation by a licensed provider, and results vary.

Frequently Asked Questions

What is ApoB and what does it measure?

ApoB (apolipoprotein B) is a blood test that counts the number of atherogenic particles in your blood, the particles that cause heart disease by lodging in the artery wall. Every LDL, VLDL, IDL, remnant, and Lp(a) particle carries exactly one ApoB molecule, so measuring ApoB is a direct headcount of those particles. LDL cholesterol, by contrast, estimates the weight of cholesterol they carry, not how many there are.

Is ApoB better than LDL cholesterol for predicting heart attacks?

The evidence says yes. In a 2022 analysis published in JAMA Cardiology, Marston and colleagues found that ApoB carried the cardiovascular risk, and once ApoB was accounted for, LDL cholesterol and triglycerides added essentially no further predictive value. Because it counts particles rather than estimating cholesterol weight, ApoB captures risk that a standard panel can miss, particularly in people with metabolic problems.

What is a good ApoB level?

Apex’s optimization target is under 80 mg/dL. The 2019 ESC/EAS guidelines set ApoB goals of under 80 mg/dL for high-risk patients and under 65 mg/dL for very-high-risk patients, while the 2018 AHA/ACC guideline flags an ApoB of 130 mg/dL or higher as a risk-enhancing factor. A lab’s “normal” range is far more permissive than an optimization target, so an ApoB that isn’t flagged is not the same as an ApoB that’s optimal. Your specific target depends on your overall risk and should be set with a provider.

Why isn’t ApoB on a standard cholesterol test?

Mostly inertia. The standard lipid panel is old, inexpensive, and universal, and it usually reports a calculated LDL cholesterol using the Friedewald equation from 1972 rather than a measured particle count. ApoB is a direct, standardized, widely available measurement that costs little to add, but it is not yet a routine default on most physicals. You often have to ask for it or seek out a clinic that runs it.

Can you have normal cholesterol and a high ApoB?

Yes, and it’s common. It’s called discordance: your LDL cholesterol looks normal while your ApoB is high because your particles are small and cholesterol-depleted, so it takes more of them to carry the same total cholesterol. This pattern shows up most in people with insulin resistance, prediabetes, type 2 diabetes, high triglycerides, or low HDL, exactly the people whose calculated LDL is also least reliable.